Glucocorticoid Receptor Polymorphisms and Intraocular Pressure Response to Intravitreal Triamcinolone Acetonide

REFERENCES

• Spaide R F, Sorenson J, Maranan L. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology. 2005; 112: 301–304
   PubMed Web of Science ®Google Scholar
• Martidis A, Duker J S, Greenberg P B, et al. Intravitreal injection of triamcinolone acetonide for refractory diabetic macular edema. Ophthalmology. 2002; 109: 920–927
   PubMed Web of Science ®Google Scholar
• Ip M S, Gottlieb J L, Kahana A, et al. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol. 2004; 122: 1131–1136
   PubMedGoogle Scholar
• Rhee D J, Peck R E, Belmont J, et al. Intraocular pressure alterations following intravitreal triamcinolone acetonide. Br J Ophthalmol. 2006; 90: 999–1003
   PubMed Web of Science ®Google Scholar
• Smithen L M, Ober M D, Maranan L, Spaide R F. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol. 2004; 138: 740–743
   PubMed Web of Science ®Google Scholar
• Quiram P A, Gonzales C R, Schwartz S D. Severe steroid-induced glaucoma following intravitreal injection of triamcinolone acetonide. Am J Ophthalmol. 2006; 141: 580–582
   PubMed Web of Science ®Google Scholar
• Kaushik S, Gupta V, Gupta A, Dogra M R, Singh R. Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion. Am J Ophthalmol. 2004; 137: 758–760
   PubMed Web of Science ®Google Scholar
• Viola F, Morescalchi F, Staurenghi G. Argon laser trabeculoplasty for intractable glaucoma following intravitreal triamcinolone. Arch Ophthalmol. 2006; 124: 133–134
   PubMed Web of Science ®Google Scholar
• Shukla D, Vidhya N, Prasad N M, et al. Evaluation of patient age as a risk factor for intraocular pressure elevation after intravitreal triamcinolone. Am J Ophthalmol. 2007; 144: 453–454
   PubMed Web of Science ®Google Scholar
• Galor A, Margolis R, Brasil O M, et al. Adverse events after intravitreal triamcinolone in patients with and without uveitis. Ophthalmology 2007; 114: 1912–1918
   PubMed Web of Science ®Google Scholar
• Palmberg P F, Mandell A, Wilensky J T, Podos S M, Becker B. The reproducibility of the intraocular pressure response to dexamethasone. Am J Ophthalmol. 1975; 80: 844–856
   PubMed Web of Science ®Google Scholar
• Becker B. Intraocular pressure response to topical corticosteroids. Invest Ophthalmol. 1965; 4: 198–205
   PubMedGoogle Scholar
• Becker B, Shin D H, Palmberg P F, Waltman S R. HLA antigens and corticosteroid response. Science. 1976; 194: 1427–1428
   Google Scholar
• Weinreb R N, Bloom E, Baxter J D, et al. Detection of glucocorticoid receptors in cultured human trabecular cells. Invest Ophthalmol Vis Sci. 1981; 21: 403–407
   PubMed Web of Science ®Google Scholar
• Tissing W J, Meijerink J P, den Boer M L, et al. Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia. Clin Cancer Res. 2005; 11: 6050–6056
   PubMed Web of Science ®Google Scholar
• van Rossum E F, Koper J W, Huizenga N A, et al. A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes. 2002; 51: 3128–3134
   PubMed Web of Science ®Google Scholar
• Huizenga N A, Koper J W, de Lange P, et al. A polymorphism in the glucocorticoid receptor gene may be associated with an increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab. 1998; 83: 144–151
   PubMed Web of Science ®Google Scholar
• van Rossum E F, Koper J W, van den Beld A W, et al. Identification of the BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo and body mass index. Clin Endocrin (Oxf). 2003; 59: 585–592
   PubMed Web of Science ®Google Scholar
• Koper J W, Stolk R P, de Lange P, et al. Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. Hum Genet. 1997; 99: 663–668
   PubMed Web of Science ®Google Scholar
• McLaren N C, Moroi S E. Clinical implications of pharmacogenomics for glaucoma therapeutics. Pharmacogenomics J. 2003; 3: 197–201
   PubMed Web of Science ®Google Scholar
• Schwartz S G, Ayala-Haedo J A, Kishor K S, Fini M E. Pharmacogenomics of open angle glaucoma. Curr Pharmacogenomics Personalized Med. 2008; 6: 121–125
   Google Scholar
• Schwartz S G, Puckett B J, Allen R C, et al. β1-adrenergic receptor polymorphisms and clinical efficacy of betaxolol hydrochloride in normal volunteers. Ophthalmology. 2005; 112: 2131–2136
   PubMed Web of Science ®Google Scholar
• Sakurai M, Higashide T, Takahashi M, Sugiyama K. Association between genetic polymorphisms of the prostaglandin F2α receptor gene and response to latanoprost. Ophthalmology. 2007; 114: 1039–1045
   PubMed Web of Science ®Google Scholar
• Zhang X, Clark A F, Yorio T. Heath shock protein 90 is an essential molecular chaperone for nuclear transport of glucocorticoid receptor beta. Invest Ophthalmol Vis Sci. 2006; 47: 700–708
   Google Scholar